One of the largest clinical trials done in infants with congenital heart diseases shows that the increasingly common practice of using the drug clopidogrel (Plavix) to reduce shunt-related blood flow issues is not effective in the dose studied.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/m...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/m...